<DOC>
	<DOCNO>NCT00971386</DOCNO>
	<brief_summary>Heart failure associate faster breathing , negative impact function heart . This lead fatigue , shortness breath , exercise intolerance . It show slow breathing technique teach patient heart failure , reduction sensation shortness breath improvement exercise performance . The study compare short-term effect control slow breathing biofeedback normal healthy subject , acute heart failure , chronic stable heart failure . The purpose see change objective measurement heart function breathe normal rate compare control slow rate .</brief_summary>
	<brief_title>Short Term Hemodynamic Effects Controlled Slow Breathing With Biofeedback Patients With Heart Failure</brief_title>
	<detailed_description>Heart Failure ( HF ) grow challenge public health concern United States . Current data suggest 5 million heart failure patient country additional 550,000 patient diagnose syndrome year first time . Despite significant advance management strategy heart failure patient last 1-2 decade , 1 million hospital admission year Acute Decompensated Heart Failure ( ADHF ) , almost double number see 15 year ago . The readmission rate patient 6-month follow discharge approach 50 % estimate 5-year mortality 50 % . Approximately , $ 23 billion spend inpatient management HF patient another $ 40 billion outpatient care . This prevailing situation mandate exploration novel therapeutic target treat complex disease . Chronic HF accompany sustain elevation sympathetic nervous system activity , think important component pathophysiology progression disease . HF patient also show abnormal breathing pattern increase respiratory rate lower tidal volume . Faster respiratory rate associate high level sympathetic activity potentiation chemoreflex response hypoxia hypercapnia . The relationship sympathetic activity spontaneous breathe rate independent age , body mass index , physical activity level , percentage body fat , blood pressure . The arterial baroreflex sensitivity also reduce patient heart failure . All factor contribute distress symptom fatigue , dyspnea exercise intolerance patient . Yoga trainee learn breathe slowly , rate six breath per minute , mobilize sequence diaphragm upper low chest . A handful study normal subject undergo intensive training yogic breathe technique demonstrate marked improvement cardiac hemodynamic parameter ( cardiac output , cardiac index , stroke volume etc . ) , study conduct patient heart failure . The purpose study evaluate change cardiac hemodynamic parameter ( cardiac output , cardiac index thoracic fluid content ) patient acute heart failure , chronic ambulatory heart failure normal healthy subject trial control slow breathing . Subjects would undergo non-invasive measurement cardiac hemodynamics spontaneously breathe . They would give instruction slow breathing rate 6 10 breath per minute ask practice time use heart rate variability biofeedback mechanism . Hemodynamic measurement would repeat trial slow breathing . The difference measurement would statistically analyze . We hypothesize even short trial control slow breathing use biofeedback mechanism patient HF would produce significant favorable improvement cardiac hemodynamics .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>NORMAL SUBJECTS 1 . Normal subject without history , signssymptoms diagnosis heart failure 2 . Age 18 willing able provide inform consent . NORMAL SUBJECTS 1 . Known allergy electrode gel medical adhesive use electrocardiographic electrode . 2 . Pregnancy ( effect device use pregnancy know ) . 3 . Patient belong vulnerable population institutionalize person , prisoner person decisional incapacity dementia . 4 . Presence severe aortic regurgitation . 5 . Second degree Mobitz type II third degree heart block , unless treat cardiac pacemaker . 6 . Implantation leave ventricular assist device , hemodynamic monitor , activate minute ventilation pacemaker , biventricular pacemaker ( Cardiac Resynchronization Therapy ) VtoV interval set 5 millisecond offset . 7 . Implantation cardiac resynchronization device within last 30 day . CHRONIC AMBULATORY HEART FAILURE 1 . Patients age 18 able give consent 2 . Ability understand willing sign inform consent 3 . Diagnosis Chronic Heart Failure currently optimal medical therapy CHRONIC AMBULATORY HEART FAILURE 1 . NYHA class III/ IV heart failure symptoms despite treatment diuretic . 2 . Coexistent pulmonary disease asthma/ COPD/ interstitial lung disease . 3 . Known allergy electrode gel medical adhesive use electrocardiographic electrode . 4 . Pregnancy ( effect device use pregnancy know ) . 5 . Patient belong vulnerable population institutionalize person , prisoner person decisional incapacity dementia . 6 . Presence severe aortic regurgitation . 7 . Second degree Mobitz type II third degree heart block , unless treat cardiac pacemaker . 8 . Implantation leave ventricular assist device , hemodynamic monitor , activate minute ventilation pacemaker , biventricular pacemaker ( Cardiac Resynchronization Therapy ) VtoV interval set 5 millisecond offset . 9 . Implantation cardiac resynchronization device within last 30 day . ACUTE HEART FAILURE 1 . Patients age 18 willing able provide inform consent . 2 . Patients admit hospital acute congestive heart failure ( evidenced pulmonary edema CXR , BNP &gt; 500 pg/ml , jugular venous distension ( JVD ) , crackles/ rale , dependent edema ) stabilize medical therapy evidence euvolemia least two follow : clearance rales/ crackle , decrease JVD , reduction peripheral edema , decrease BNP least 20 % , evidence pulmonary edema CXR . ACUTE HEART FAILURE 1 . NYHA class III/ IV despite treatment diuretic . 2 . Coexistent pulmonary disease asthma/ COPD/ interstitial lung disease . 3 . Known allergy electrode gel medical adhesive use electrocardiographic electrode . 4 . Pregnancy ( effect device use pregnancy know ) .. 5 . Patient belong vulnerable population institutionalize person , prisoner person decisional incapacity dementia . 6 . Presence severe aortic regurgitation . 7 . Second degree Mobitz type II third degree heart block , unless treat cardiac pacemaker . 8 . Implantation leave ventricular assist device , hemodynamic monitor , activate minute ventilation pacemaker , biventricular pacemaker ( Cardiac Resynchronization Therapy ) VtoV interval set 5 millisecond offset . 9 . Implantation cardiac resynchronization device within last 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Heart Failure</keyword>
</DOC>